Bionano Genomics, Inc. (BNGO)
0.8999
+0.01
(+1.68%)
USD |
NASDAQ |
Nov 20, 10:10
Bionano Genomics Cash from Operations (Quarterly) : -4.524M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -4.524M |
| June 30, 2026 | -4.67M |
| March 31, 2026 | -5.716M |
| December 31, 2025 | -4.175M |
| September 30, 2025 | -5.919M |
| June 30, 2025 | -3.487M |
| March 31, 2025 | -2.764M |
| December 31, 2024 | -6.807M |
| September 30, 2024 | -13.31M |
| June 30, 2024 | -22.42M |
| March 31, 2024 | -28.13M |
| December 31, 2023 | -34.30M |
| September 30, 2023 | -26.29M |
| June 30, 2023 | -36.70M |
| March 31, 2023 | -32.41M |
| December 31, 2022 | -34.52M |
| September 30, 2022 | -29.47M |
| June 30, 2022 | -28.33M |
| March 31, 2022 | -32.49M |
| December 31, 2021 | -25.62M |
| Date | Value |
|---|---|
| September 30, 2021 | -19.98M |
| June 30, 2021 | -12.42M |
| March 31, 2021 | -13.90M |
| December 31, 2020 | -12.10M |
| September 30, 2020 | -10.96M |
| June 30, 2020 | -7.218M |
| March 31, 2020 | -8.032M |
| December 31, 2019 | -9.484M |
| September 30, 2019 | -7.177M |
| June 30, 2019 | -6.317M |
| March 31, 2019 | -6.551M |
| December 31, 2018 | -4.090M |
| September 30, 2018 | -6.100M |
| June 30, 2018 | -2.966M |
| March 31, 2018 | -6.788M |
| December 31, 2017 | |
| September 30, 2017 | -5.655M |
| June 30, 2017 | -4.988M |
| March 31, 2017 | -7.366M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 519.00M |
| Bio-Rad Laboratories, Inc. | 96.40M |
| Bruker Corp. | 118.20M |
| Danaher Corp. | 1.886B |
| Harvard Bioscience, Inc. | -0.248M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.411M |
| Cash from Financing (Quarterly) | 2.737M |
| Free Cash Flow | -19.08M |
| Free Cash Flow Per Share (Quarterly) | -0.3773 |
| Free Cash Flow to Equity (Quarterly) | -4.363M |
| Free Cash Flow to Firm (Quarterly) | -4.459M |
| Free Cash Flow Yield | -157.0% |